Publication:
Clinicopathological features and outcomes of pythiosis

dc.contributor.authorMaria Nina Chitasombaten_US
dc.contributor.authorNoppadol Larbcharoensuben_US
dc.contributor.authorAriya Chindampornen_US
dc.contributor.authorTheerapong Krajaejunen_US
dc.contributor.otherChulalongkorn Universityen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2019-08-28T06:06:18Z
dc.date.available2019-08-28T06:06:18Z
dc.date.issued2018-06-01en_US
dc.description.abstract© 2018 The Author(s) Objectives: Vascular pythiosis is a life-threatening infection caused by the oomycete Pythium insidiosum. This article reports the clinical presentation, serodiagnosis, pathology, and outcomes seen at the authors’ institution. Methods: The cases of patients with proven vascular pythiosis at Ramathibodi Hospital, Mahidol University, Bangkok, Thailand from January 2006 to December 2016 were analyzed retrospectively. Results: Thirteen patients were analyzed, eight of whom had underlying thalassemias. Of the remaining five patients, one had aplastic anemia, one had myelodysplasia, one had acute leukemia, one had cirrhosis, and one had alcoholism. Neutropenic patients showed a rapid clinical deterioration. Atypical presentations including carotid arteritis, aneurysm, brain abscess, and stroke occurred in the non-thalassemic patients. Serology yielded positive results in all cases, with a rapid turnaround time. Serology has the advantage of providing a presurgical diagnosis, which allows prompt surgery and clinical cure to be achieved. Pathology revealed a neutrophilic response in the acute phase and a later shift to granuloma. Immunotherapy in combination with itraconazole and terbinafine was given. The amputation rate was 77%, and disease-free surgical margins were achieved in five cases (38%). The mortality rate was 31%. Conclusions: This study highlights new aspects of pythiosis, such as the unusual host, clinical presentation, serology as a marker for rapid diagnosis, histopathology, and outcomes. Early recognition of the disease with prompt multimodality treatment may improve survival.en_US
dc.identifier.citationInternational Journal of Infectious Diseases. Vol.71, (2018), 33-41en_US
dc.identifier.doi10.1016/j.ijid.2018.03.021en_US
dc.identifier.issn18783511en_US
dc.identifier.issn12019712en_US
dc.identifier.other2-s2.0-85046663889en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/46619
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85046663889&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleClinicopathological features and outcomes of pythiosisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85046663889&origin=inwarden_US

Files

Collections